3.238.176.43
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Interstitial Lung Disease

More studies needed to determine risk of ILD with CDK4/6 inhibitors

Due to increases in reports of interstitial lung disease (ILD) with CDK4/6 inhibitors as a class, CDK4/6 inhibitors should be included with other drugs that may induce ILD, according to a study. This observational, retrospective pharmacovigilance analysis used data from the FDA Adverse Event Reporting System (FAERS). There was a total...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-